Volume 25 - Issue 8 - August 2017

A FDA advisory panel has recently voted that the safety and efficacy of a shingles vaccine warrants approval for its use in adults aged 50 and over.
Jane Clark, MD, and Emily Jorge, DCNP, FNP-BC
Amanda Rusk, MSIV; Nina N. Rettig, PA-C; Sri Krishna Chaitanya Arudra, MD; Jean E. Thomas, MD; and Lorie Gottwald, MD
Miriam Emily Piansay-Soriano, MD, FPDS, and Jean Anne Coronica-Soroan, MD
Section Editor, Benjamin Barankin, MD, FRCPC